Fujisawa Pharmaceutical Co., Ltd

Headquarters location: 4-7, Doshomachi 3-chome, Chuo-ku, Osaka 541-8514 Tel. 6-6202-1141 Job offers, investor relations: www.fujisawa.co.jp

Fujisawa Pharmaceutical belongs to shareholder country     % source Bank of Tokyo - Mitsubishi Chase Manhattan Corp. Daido Life Insurance Co. Japan Trustee Services Bank Ltd Mitsubishi Trust & Banking Nippon Fire & Marine Insurance Co. Nippon Life Insurance Co. Sanwa Bank Tokai Bank Ltd. Toyo Trust & Banking Co.	Brands name items photo compare the prices Analytical Science Laboratories Ethishop Daisan Kogyo Ethishop Doei Ethishop F.I.T.E Ethishop Fujisawa Pharmaceutical Ethishop Gakuei Ethishop Hoshienu Pharmaceutical Ethishop Klinge Pharma Ethishop Koei Ethishop PMP Fermentation Products Ethishop Rainbow Tourist Ethishop Ribosepharm Ethishop Serachem Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF FUJISAWA_PHARMACEUTICAL , group and subsidiaries [?] 1 Delinquency: 1 act(s) of financial or trade delinquency 3 Tax haven, secret bank account, shell companies: operates in 3 offshore financial center(s) 1 Influence: 1 act(s) of direct corruption or lobbying Full profile >>>
World locations & Manufacturing country incentive : address & contact : production type source   Fujisawa Korea Ltd. 10F. Haesung No.1 Bldg., 942, Kangnam-ku, Seoul & 2-564-3180 : Fujisawa Hong Kong Ltd. Grand Century Place, 193 Prince Edward Road West, Mongkok, Kowloon & 852-2377-9801 : Killorgin : R&D Les Echos Fujisawa Ireland Ltd : Klinge Pharma AG, Bachstrasse 10, CH-8280 Kreuzlingen & 71-6724882 : The map of tax haven, secret accounts and shell companies Fujisawa Pharmaceutical is managed by year name photo position; compensation source 2000Aoki, Hatsuo Chief Executive Officer; 2000Fujisawa, Tomokichiro Director; 2000Fujiyama, Akira Chairman of the Board; 2000Iida, Michio Vice-president; 2000Kobayashi, Kanji Director; 2000Kojima, Akiro Director; Highest paid executives in 2007

Made by year employees <> social impact : country source 2003 8000 2002 7700 Layoff plans and labour conditions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. Influence in 2007 Financials year financial misdemeanor sales income source 2003   3.19 0.24   billion US$ 2002   2.57 0.2   billion US$ 2002 Fined for fixing the price and sharing the european market for sodium gluconate: 3,6 million euros.     Commission. 2001   2.36 0.16   billion US$ 2000   2.74 0.22   billion US$ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Aig american group   AIG's Loss, Capital Needs Renew Doubts About Sullivan's Tenure - Friday 9 May 2008 at 08h30

Target   Target writes off 8.1% of its annualized credit card debt in March - Friday 2 May 2008 at 11h07

Dell computer   Dell confirms plan to cut 250 Irish jobs - Friday 2 May 2008 at 08h50

Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08

Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09

All comments